Pharmacokinetic Drug Interactions between HMG-COA Reductase Inhibitors Fluvastatin with Concomitantly administered Ticagrelor Siddiqui M A Hakeem1, Roshan S2,* 1Research, Scholar, Mewar, University, Chittorgarh, Rajasthan, India 2Research Supervisor, Mewar University, Chittorgarh, Rajasthan, India *Corresponding Author E-mail: roshansalfi@yahoo.com
Online published on 12 June, 2018. Abstract The present study was aimed to carry out any possible pharmacokinetic interactions between fluvastatin and ticagrelor. Study was conducted in Male Wistar rats; animals were divided in to three groups, Group I: Fluvastatin alone in single dose/day in healthy rats. Group II: ticagrelor alone in single dose/day in healthy rats. Group III: Fluvastatin and ticagrelor concomitant administration in healthy rats as a single dose/day. And the treatment was given on day one and day 8 both alone Fluvastatin and ticagrelor and concomitantly used both the drugs. The results were showed no significant difference in the tmax of Fluvastatin alone and combination with ticagrelor on day 1 and day 8 respectively. These were no significant difference in both cmax and tmax of ticagrelor alone and combination of Fluvastatin on day 1 and day 8 respectively. And there was no significance difference in AUC0-t and AUCo-inf also in alone and combination of both drugs on day 1 and day 8th. Based on the results obtained from kinetic study it is evident that the single dose of Fluvastatin with ticagrelor individually and concomitantly treated shows no statistically significant interactions in its pharmacokinetic parameters Top Keywords Fluvastatin, ticagrelor, Pharmacokinetic parameters. Top |